Definium Therapeutics, Inc. Common Shares (DFTX) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for DFTX. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 348 institutions reported holding DFTX, with 114.8 million shares worth $5.3 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 11,232,834 | $528M | INCREASED |
| Capital Group | 8,331,133 | $392M | NEW |
| Avoro Capital Advisors | 7,188,888 | $338M | INCREASED |
| Driehaus Capital Management | 6,845,276 | $322M | INCREASED |
| Janus Henderson (Jupiter Topco) | 5,615,645 | $264M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Daniel Karlin (Chief Medical Officer) | SELL | 10,853 | $397K | 2026-09-25 |
| Robert Barrow (Chief Executive Officer) | SELL | 31,550 | $1M | 2026-09-25 |
| Matthew T. Wiley (Chief Commercial Officer) | SELL | 3,097 | $113K | 2026-09-25 |
| Mark Sullivan (Chief Legal Officer) | SELL | 14,051 | $514K | 2026-09-25 |
| Brandi Roberts (Chief Financial Officer) | SELL | 3,377 | $123K | 2026-09-25 |
Full institutional holdings, insider history, and congressional trades for Definium Therapeutics, Inc. Common Shares on SentiSense.